FDA Inspection 976603 — Bioreliance Ltd.
The FDA completed an inspection of Bioreliance Ltd. on Mar 17, 2016 in Stirling, Scotland. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 17, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Stirling, Scotland (United Kingdom)